Published, Version of Record (VoR)CC BY V4.0, Open
Abstract
Life Sciences & Biomedicine Microbiology Parasitology Science & Technology Virology
The zinc finger antiviral protein (ZAP) is a mammalian host restriction factor that inhibits the replication of a variety of RNA viruses, including retroviruses, alphaviruses and filoviruses, through interaction with the ZAP-responsive elements (ZRE) in viral RNA, and recruiting the exosome to degrade RNA substrate. Hepatitis B virus (HBV) is a pararetrovirus that replicates its genomic DNA via reverse transcription of a viral pregenomic (pg) RNA precursor. Here, we demonstrate that the two isoforms of human ZAP (hZAP-L and -S) inhibit HBV replication in human hepatocyte-derived cells through posttranscriptional down-regulation of viral pgRNA. Mechanistically, the zinc finger motif-containing N-terminus of hZAP is responsible for the reduction of HBV RNA, and the integrity of the four zinc finger motifs is essential for ZAP to bind to HBV RNA and fulfill its antiviral function. The ZRE sequences conferring the susceptibility of viral RNA to ZAP-mediated RNA decay were mapped to the terminal redundant region (nt 1820-1918) of HBV pgRNA. In agreement with its role as a host restriction factor and as an innate immune mediator for HBV infection, ZAP was upregulated in cultured primary human hepatocytes and hepatocyte-derived cells upon IFN-alpha treatment or IPS-1 activation, and in the livers of hepatitis B patients during immune active phase. Knock down of ZAP expression increased the level of HBV RNA and partially attenuated the antiviral effect elicited by IPS-1 in cell cultures. In summary, we demonstrated that ZAP is an intrinsic host antiviral factor with activity against HBV through down-regulation of viral RNA, and that ZAP plays a role in the innate control of HBV replication. Our findings thus shed light on virus-host interaction, viral pathogenesis, and antiviral approaches.
Inhibition of Hepatitis B Virus Replication by the Host Zinc Finger Antiviral Protein
Creators
Richeng Mao - Drexel University
Hui Nie - Drexel University
Dawei Cai - Drexel University
Jiming Zhang - Huashan Hospital
Hongyan Liu - Huashan Hospital
Ran Yan - Drexel University
Andrea Cuconati - Hepatitis B Foundation
Timothy M. Block - Drexel University
Ju-Tao Guo - Drexel University
Haitao Guo - Drexel University
Publication Details
PLoS pathogens, v 9(7), pp e1003494-e1003494
Publisher
Public Library Science
Number of pages
18
Grant note
2012ZX10002007-001-002; 2013ZX10002001 / Major Science and Technology Special Project
81071354; 81201277 / National Natural Science Foundation of China; National Natural Science Foundation of China (NSFC)
Hepatitis B Foundation
Hepatitis B Foundation through Commonwealth of Pennsylvania
R21AI088424 / NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)
R21AI088424; R01AI094474 / National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
20120071120099 / Doctoral Fund of Ministry of Education of China; Ministry of Education, China
Chinese Scholarship Council; China Scholarship Council
Resource Type
Journal article
Language
English
Academic Unit
Microbiology and Immunology
Web of Science ID
WOS:000322316700037
Scopus ID
2-s2.0-84884747041
Other Identifier
991019168485104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: